Correction to: PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression (Pharmaceutics, (2022), 14, 7, (1326), 10.3390/pharmaceutics14071326)

Simple item page
dc.contributor.authorYadav N.
dc.contributor.authorTripathi A.K.
dc.contributor.authorParveen A.
dc.contributor.authorParveen S.
dc.contributor.authorBanerjee M.
dc.date.accessioned2025-01-13T07:09:04Z
dc.date.available2025-01-13T07:09:04Z
dc.date.issued2024
dc.description.abstractIn the published publication [1], there was an error regarding the affiliation for Neera Yadav. In addition to affiliation 1, the updated affiliation should include: Molecular and Human Genetics Lab, Department of Zoology, University of Lucknow, Lucknow 226007, India. Neera Yadav did not act as the corresponding author any more. Shama Parveen and Monisha Banerjee (the corresponding author) were not included as authors in the original publication [1]. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Shama Parveen: investigation, formal analysis, methodology; Monisha Banerjee: project administration, funding acquisition, resources, supervision, writing�review and editing. The authors also acknowledge Ratan Singh Ray, CSIR-Indian Institute of Toxicology Research (IITR), Lucknow, India, for the synthesis of nanoparticles; Birbal Sahni Institute of Palaeosciences (BSIP), Lucknow, for the SEM facility; Centre of Excellence, Higher Education Government of Uttar Pradesh for the cell culture facility at the Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow-226007, India. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor and Editor-in-Chief. The original publication has also been updated. � 2024 by the authors.
dc.identifier.doi10.3390/pharmaceutics16010124
dc.identifier.issn19994923
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/3523
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.titleCorrection to: PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression (Pharmaceutics, (2022), 14, 7, (1326), 10.3390/pharmaceutics14071326)
dc.typeErratum
journal.titlePharmaceutics
journalvolume.identifier.volume16

Files

Collections

2024